SRC
DGX icon

Shufro Rose & Co’s Quest Diagnostics DGX Stock Holding History

Shufro Rose & Co’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$514K Hold
2,622
– – 0.03% 185
2025
Q4 		$455K Sell
2,622
-628
-19% -$114K 0.03% 189
2025
Q3 		$550K Sell
3,250
-700
-18% -$124K 0.04% 169
2025
Q2 		$668K Hold
3,950
– – 0.05% 147
2025
Q1 		$668K Hold
3,950
– – 0.05% 148
2024
Q4 		$596K Sell
3,950
-100
-2% -$15.6K 0.05% 154
2024
Q3 		$554K Hold
4,050
– – 0.05% 164
2024
Q2 		$554K Hold
4,050
– – 0.05% 164
2024
Q1 		$539K Sell
4,050
-50
-1% -$6.49K 0.04% 163
2023
Q4 		$500K Hold
4,100
– – 0.05% 160
2023
Q3 		$500K Sell
4,100
-150
-4% -$20K 0.05% 159
2023
Q2 		$597K Hold
4,250
– – 0.05% 146
2023
Q1 		$601K Sell
4,250
-2,650
-38% -$379K 0.06% 152
2022
Q4 		$1.08M Sell
6,900
-400
-5% -$57.5K 0.09% 111
2022
Q3 		$896K Hold
7,300
– – 0.09% 115
2022
Q2 		$971K Hold
7,300
– – 0.08% 115
2022
Q1 		$999K Hold
7,300
– – 0.08% 125
2021
Q4 		$1.26M Sell
7,300
-100
-1% -$15.2K 0.09% 109
2021
Q3 		$1.07M Hold
7,400
– – 0.08% 112
2021
Q2 		$977K Hold
7,400
– – 0.07% 119
2021
Q1 		$950K Sell
7,400
-215
-3% -$26.5K 0.08% 118
2020
Q4 		$907K Hold
7,615
– – 0.08% 118
2020
Q3 		$872K Hold
7,615
– – 0.08% 110
2020
Q2 		$868K Hold
7,615
– – 0.09% 108
2020
Q1 		$611K Sell
7,615
-100
-1% -$10.4K 0.07% 125
2019
Q4 		$824K Hold
7,715
– – 0.07% 126
2019
Q3 		$826K Sell
7,715
-200
-3% -$20.5K 0.08% 121
2019
Q2 		$806K Sell
7,915
-100
-1% -$9.61K 0.08% 128
2019
Q1 		$721K Sell
8,015
-300
-4% -$26K 0.07% 137
2018
Q4 		$692K Sell
8,315
-50
-0.6% -$4.69K 0.08% 138
2018
Q3 		$903K Sell
8,365
-300
-3% -$32.9K 0.08% 133
2018
Q2 		$953K Sell
8,665
-250
-3% -$26K 0.09% 125
2018
Q1 		$894K Hold
8,915
– – 0.09% 126
2017
Q4 		$878K Sell
8,915
-200
-2% -$19K 0.09% 130
2017
Q3 		$854K Sell
9,115
-400
-4% -$42.5K 0.09% 129
2017
Q2 		$1.06M Sell
9,515
-350
-4% -$37K 0.11% 112
2017
Q1 		$969K Buy
9,865
+385
+4% +$36.7K 0.1% 120
2016
Q4 		$871K Sell
9,480
-100
-1% -$8.62K 0.1% 120
2016
Q3 		$811K Sell
9,580
-1,100
-10% -$92.4K 0.09% 120
2016
Q2 		$869K Sell
10,680
-150
-1% -$11.4K 0.1% 120
2016
Q1 		$774K Buy
10,830
+750
+7% +$50.3K 0.09% 135
2015
Q4 		$717K Hold
10,080
– – 0.08% 134
2015
Q3 		$619K Hold
10,080
– – 0.07% 144
2015
Q2 		$731K Buy
10,080
+100
+1% +$7.38K 0.08% 138
2015
Q1 		$766K Sell
9,980
-137,795
-93% -$9.87M 0.08% 138
2014
Q4 		$9.91M Sell
147,775
-6,700
-4% -$423K 1.01% 31
2014
Q3 		$9.37M Sell
154,475
-920
-0.6% -$56.7K 0.97% 36
2014
Q2 		$9.12M Sell
155,395
-1,500
-1% -$87.8K 0.94% 38
2014
Q1 		$9.09M Sell
156,895
-1,510
-1% -$80.9K 0.95% 35
2013
Q4 		$8.48M Buy
158,405
+8,840
+6% +$524K 0.9% 36
2013
Q3 		$9.24M Sell
149,565
-2,550
-2% -$153K 1.05% 29
2013
Q2 		$9.22M Buy
+152,115
New +$9.06M 1.1% 29

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Shufro Rose & Co's DGX Position: Q1 2026 in Review

Shufro Rose & Co held its Quest Diagnostics (DGX) position steady in Q1 2026 at 2,622 shares worth $514K. The position accounts for 0.03% of the portfolio, ranked #185.

Shufro Rose & Co first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.91M in Q4 2014. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Shufro Rose & Co held 2,622 shares of Quest Diagnostics worth $514K as of Q1 2026.
  • Shufro Rose & Co left its Quest Diagnostics share count unchanged in Q1 2026.
  • Quest Diagnostics made up 0.03% of Shufro Rose & Co's portfolio in Q1 2026, its #185 holding.
  • Shufro Rose & Co first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
  • Shufro Rose & Co's Quest Diagnostics position peaked at $9.91M in Q4 2014.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Shufro Rose & Co's 13F filing for Q1 2026, filed 15 May 2026.